Polaris Group   Report issue

For profit Phase 1 Phase 3
Founded: San Diego CA United States (2006)

Organization Overview

First Clinical Trial
2011
NCT01266018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Polaris Group